Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study

Hjalmar Flygt, Stina Söderlund, Jesper Stentoft, Johan Richter, Perttu Koskenvesa, Satu Mustjoki, Waleed Majeed, Anna Lübking, Arta Dreimane, Berit Markevärn, Leif Stenke, Kristina Myhr Eriksson, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Andreja Dimitrijevic, Lene Udby, Ulla Olsson-Strömberg, Henrik Hjorth-Hansen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study'. Together they form a unique fingerprint.

Medicine & Life Sciences